Audit 301024

Title: 4. SUBRECIPIENTS Accounting Policies: 1. BASIS OF PRESENTATION The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Washington Health Institute, under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Washington Health Institute, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Washington Health Institute. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, Cost Principles for Non-Profit Organizations, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: Both Rate Explanation: 3. INDIRECT COSTS Washington Health Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. Washington Health Institute has negotiated a 34% indirect rate with George Washington University for the Allergy and Infectious Diseases Research program. The District of Columbia Department of Health limits indirect cost recovery to 10% for the HIV Emergency Relief Project Grants and the HIV Care Formula Grants. Washington Health Institute does not have any subrecipients.

Title: 5. RECONCILIATION OF EXPENDITURES Accounting Policies: 1. BASIS OF PRESENTATION The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of Washington Health Institute, under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Washington Health Institute, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Washington Health Institute. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, Cost Principles for Non-Profit Organizations, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: Both Rate Explanation: 3. INDIRECT COSTS Washington Health Institute has elected not to use the 10% de minimis indirect cost rate as allowed under the Uniform Guidance. Washington Health Institute has negotiated a 34% indirect rate with George Washington University for the Allergy and Infectious Diseases Research program. The District of Columbia Department of Health limits indirect cost recovery to 10% for the HIV Emergency Relief Project Grants and the HIV Care Formula Grants. The financial statements of Washington Health Institute are presented in accordance with U.S. generally accepted accounting principles. Expenditures per the schedule of expenditures of federal awards are reported on the statement of activities in the audited financial statements as follows: See the Notes to the SEFA for chart/table.